DCF Advisers, LLC
Top Portfolio Positions
70 positions ·
$329,640,133 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| QQQ |
Invesco Qqq Trust, Series 1
|
126,000 | $72,724,680 | 22.06% | |
| MU |
Micron Technology Inc
Technology
|
150,000 | $50,676,000 | 15.37% | |
| SPY |
Spdr S&P 500 ETF Trust
|
21,500 | $13,982,310 | 4.24% | |
| ARGX |
Argenx SE
Healthcare
|
14,650 | $10,698,162 | 3.25% | |
| CRVS |
Corvus Pharmaceuticals, Inc.
Healthcare
|
637,500 | $9,326,625 | 2.83% | |
| TEVA |
Teva Pharmaceutical Industries Ltd
Healthcare
|
300,000 | $9,036,000 | 2.74% | |
| IAU |
Ishares Gold Trust
|
100,000 | $8,816,000 | 2.67% | |
| AMZN |
Amazon Com Inc
Consumer Cyclical
|
40,500 | $8,434,935 | 2.56% | |
| LLY |
ELI LILLY & Co
Healthcare
|
8,300 | $7,634,091 | 2.32% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
9,250 | $7,146,920 | 2.17% |
Portfolio Trend
25 quarters · across all stocks
Holdings in BHVN
Shares Held
Position Value (USD)
12 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,044,810 | 123,500 | Shares | Sole | 2026-05-11 | |
| 2026-03-31 | $1,137,870 | 134,500 | Call | Sole | 2026-05-11 | |
| 2025-12-31 | $1,710,435 | 151,500 | Shares | Sole | 2026-02-11 | |
| 2025-12-31 | $530,630 | 47,000 | Call | Sole | 2026-02-11 | |
| 2025-09-30 | $90,060 | 6,000 | Call | Sole | 2025-11-12 | |
| 2025-09-30 | $2,574,215 | 171,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $797,215 | 56,500 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,214,020 | 50,500 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $1,344,600 | 36,000 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,549,070 | 31,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $52,065 | 1,500 | Put | Sole | 2024-08-12 | |
| 2024-06-30 | $1,794,507 | 51,700 | Shares | Sole | 2024-08-12 | |
| No 13F history on record for this holder in this stock. | ||||||